Asymmetric Synthesis of the <i>cis</i>-1,2-Diaryltetralin Vepdegestrant Core via an Enantioselective Intramolecular Corey-Chaykovsky Epoxidation

An asymmetric synthesis of cis-1,2-diaryltetralin (2), a key chiral intermediate in the synthesis of Vepdegestrant (1), an orally available PROTAC being evaluated for the treatment of ER+/HER2- breast cancer, is reported. Chirality is initially introduced via a catalytic enantioselective intramolecular Corey-Chaykovsky epoxidation utilizing isothiocineole, a chiral sulfide. Although several asymmetric intermolecular epoxidations using chiral sulfides have been reported, our approach represents a unique intramolecular variant. The subsequent introduction of the cis-1,2-diaryl motif is achieved via diastereoselective hydrogenation.

Authors

Institutions

Publication Details

Journal
Organic Process Research & Development
Published
2024-11-08
DOI
https://doi.org/10.1021/acs.oprd.4c00379
Citations
10
Primary Topic
Asymmetric Synthesis and Catalysis
Type
article
Field-Weighted Citation Impact
2.50
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Asymmetric Synthesis of the cis-1,2-Diaryltetralin Vepdegestrant Core via an Enantioselective Intramolecular Corey-Chaykovsky Epoxidation

David J. Bernhardson, Robert A. Singer, Liam S. Sharninghausen, Zebediah C. Girvin et al.
10 citations
Organic Process Research & Development
Asymmetric Synthesis and Catalysis
2.50
article

Asymmetric Synthesis of the cis-1,2-Diaryltetralin Vepdegestrant Core via an Enantioselective Intramolecular Corey-Chaykovsky Epoxidation

David J. Bernhardson, Robert A. Singer, Liam S. Sharninghausen, Zebediah C. Girvin, Yexenia Nieves‐Quinones, J. Christopher McWilliams, Zheng Wang, Sarai Lara-Boykin
article en
10 citations

Abstract

An asymmetric synthesis of cis-1,2-diaryltetralin (2), a key chiral intermediate in the synthesis of Vepdegestrant (1), an orally available PROTAC being evaluated for the treatment of ER+/HER2- breast cancer, is reported. Chirality is initially introduced via a catalytic enantioselective intramolecular Corey-Chaykovsky epoxidation utilizing isothiocineole, a chiral sulfide. Although several asymmetric intermolecular epoxidations using chiral sulfides have been reported, our approach represents a unique intramolecular variant. The subsequent introduction of the cis-1,2-diaryl motif is achieved via diastereoselective hydrogenation.

Organic Process Research & DevelopmentVol. 28(12)
Pfizer (United States) (US)
Good health and well-being
Openalex Percentile: Top 11%
Asymmetric Synthesis and Catalysis
2.50
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Asymmetric Synthesis of the <i>cis</i>-1,2-Diaryltetralin Vepdegestrant Core via an Enantioselective Intramolecular Corey-Chaykovsky Epoxidation — David J. Bernhardson, Robert A. Singer, et al. · Organic Process Research & Development (2024) | TGRS Research Map | TGRS